- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05588921
LensAge to Reveal Biological Age
October 19, 2022 updated by: Haotian Lin, Sun Yat-sen University
A Deep Learning-based Indicator to Reveal Biological Age Using Lens Photographs
Assessment of aging is central to health management.
Compared to chronological age, biological age can better reflect the aging process and health status; however, an effective indicator of biological age in clinical practice is lacking.
Human lens accumulates biological changes during aging and is amenable to a rapid and objective assessment.
Therefore, the investigators will develop LensAge as an innovative indicator to reveal biological age based on deep learning using lens photographs.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Anticipated)
6000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Haotian Lin, M.D., Ph.D.
- Phone Number: +86-020-87330274
- Email: gddlht@aliyun.com
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510060
- Recruiting
- Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity
-
Contact:
- Haotain Lin, M.D., Ph.D.
- Email: gddlht@aliyun.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 98 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Participants aged 20 to 90 have anterior segment photographs, baseline information, and medical records.
Description
Inclusion Criteria:
- ages from 20 to 100 years
- have anterior segment photographs
- have ophthalmic and physical examination records
Exclusion Criteria:
- have a history of previous eye surgery, eye trauma, or ocular diseases that can cause complicated cataracts
- baseline information missing
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
---|
Aging group
Participants with baseline information, medical history of diseases, and lens photographs
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The difference between LensAge and chronological age
Time Frame: Baseline
|
The age estimation models based on a convolutional neural network (CNN) using lens photographs will be used to generate LensAge.
LensAge at the individual level will be calculated by averaging the results of all images corresponding to one individual.
The difference between LensAge at the individual level and chronological age will be used to unveil an individual's aging process.
A difference above 0 indicates an individual with a faster pace of aging than their peers of the same chronological age, while a difference below 0 indicates a slower pace of aging.
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlation between the LensAge difference and age-related health parameters
Time Frame: Baseline
|
Age-corrected LensAge differences will be used to investigate the odds ratios (ORs) with age-related health parameters.
|
Baseline
|
Mean absolute error (MAE) of the DL age estimation model.
Time Frame: Baseline
|
Mean absolute error (MAE) in terms of both image level and individual level will be used to evaluate the performance of the DL age estimation model.
|
Baseline
|
Mean error (ME) of the DL age estimation model.
Time Frame: Baseline
|
Mean error (ME) in terms of both image level and individual level will be used to evaluate the performance of the DL age estimation model.
|
Baseline
|
R-squared (R2) of the DL age estimation model.
Time Frame: Baseline
|
R-squared (R2) in terms of both image level and individual level will be used to evaluate the performance of the DL age estimation model.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Haotian Lin, M.D., Ph.D., Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2020
Primary Completion (Anticipated)
December 30, 2022
Study Completion (Anticipated)
December 30, 2022
Study Registration Dates
First Submitted
October 17, 2022
First Submitted That Met QC Criteria
October 17, 2022
First Posted (Actual)
October 20, 2022
Study Record Updates
Last Update Posted (Actual)
October 21, 2022
Last Update Submitted That Met QC Criteria
October 19, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LA-2022
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lens Opacities
-
Cutting Edge SAStargomedGmbHRecruitingCataract | Lens OpacitiesSingapore, Spain, Czechia, Germany, Philippines, Austria
-
Sophie JACOBCompletedCataracts | Lens OpacitiesFrance
-
Cutting Edge SAStargomedGmbHRecruitingCataract | Lens OpacitiesSpain, Czechia
-
Beaver-Visitec International, Inc.targomedGmbHCompletedCataract | Lens OpacitiesSwitzerland
-
Beaver-Visitec International, Inc.CompletedCataract | Lens OpacitiesBelgium
-
Beaver-Visitec International, Inc.targomedGmbHRecruiting
-
Benha UniversityRecruitingCataract | Lens Diseases | Lens OpacitiesEgypt
-
Beaver-Visitec International, Inc.targomedGmbHActive, not recruitingCataract | Lens OpacitiesSpain, Germany, Philippines, Czechia, Austria, Ireland
-
Beaver-Visitec International, Inc.Completed
-
Beaver-Visitec International, Inc.CompletedCataract | Lens OpacitiesCzechia